Cimeio Therapeutics
Basel, Switzerland- and Boston, MA-based biotechnology company developing a novel approach to cell therapies
Basel, Switzerlandwww.cimeio.com ↗
Total raised
€330M
€329,804,329
Funding rounds
2
Investors
2
distinct backers
Active since
2022-04
latest 2024-12
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood37
base rate 30% for Other
- ▲ In typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood17
base rate 12% (2+ rounds)
- ▲ €100M+ raised
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-12-12 | Other | €283M | Kyowa Kirin | View deal → |
| 2022-04-18 | Series A | €46M | Versant Ventures | View deal → |
Investors
2Related news
- Cimeio Therapeutics Raises $50M in Series A Fundingfinsmes.com · 2022-04
- startupticker.ch
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Climeworks€920MSwitzerland · Cleantech
- Energy Vault€896MSwitzerland · Energy